Related Experiment Video
Updated: May 12, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Aberrant microRNA expression in multiple myeloma
Konstantinos Dimopoulos1, Peter Gimsing, Kirsten Grønbæk
1Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Abstract:
Multiple myeloma (MM) is a devastating disease with a complex biology, and in spite of improved survivability by novel treatment strategies over the last decade, MM is still incurable by current therapy. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression at a post-transcriptional level. More than half of all protein coding genes are estimated to be controlled by miRNAs, and their expression is frequently deregulated in many diseases, including cancer. Recent studies have reported aberrant miRNA expression patterns in MM, and the function of individual miRNAs in MM has been investigated in detail in cell culture and animal models. Here, we review the current knowledge on the role of miRNAs in MM pathogenesis and discuss their potential as prognostic biomarkers and targets for treatment.
Insights
MicroRNAs (miRNAs) play a key role in multiple myeloma (MM) development. This review explores their function, potential as biomarkers, and therapeutic targets for this incurable cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Multiple myeloma (MM) is a complex and incurable blood cancer.
- Despite advances, novel therapeutic strategies are urgently needed.
- MicroRNAs (miRNAs) are regulators of gene expression frequently altered in cancer.
Purpose of the Study:
- To review the current understanding of miRNA roles in MM pathogenesis.
- To discuss the potential of miRNAs as prognostic biomarkers for MM.
- To explore miRNAs as novel therapeutic targets for MM treatment.
Main Methods:
- Literature review of recent studies on miRNAs in MM.
- Analysis of miRNA expression patterns in MM.
- Investigation of miRNA functions in MM cell culture and animal models.
Main Results:
- Aberrant miRNA expression is frequently observed in MM.
- Specific miRNAs have been identified with roles in MM development and progression.
- miRNAs regulate key cellular processes relevant to MM pathogenesis.
Conclusions:
- miRNAs are significantly implicated in the pathogenesis of multiple myeloma.
- miRNAs show promise as valuable prognostic biomarkers.
- Targeting miRNAs offers a potential new therapeutic avenue for MM.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation